World's Best Scientists 2026 revealed!
Rolando Cimaz

Rolando Cimaz

D-Index & Metrics

Medicine

D-Index
86
Citations
28135
World Ranking
14097
National Ranking
536

Rolando Cimaz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rolando Cimaz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 678 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rolando Cimaz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rolando Cimaz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rolando Cimaz is affiliated with the University of Milan in Italy and has a significant body of work focusing on medical research, particularly related to pediatric rheumatology and autoimmune disorders. Their expertise covers a broad range of topics within medicine, contributing extensively to both clinical and translational research.

Their main field of study is Medicine, with notable contributions in the subfields of Surgery, Hematology, Rheumatology, Immunology, and Molecular Biology. Cimaz's research addresses complex inflammatory and autoimmune conditions with a particular focus on pediatric populations.

Main topics explored in their work include:

  • Autoimmune and Inflammatory Disorders Research
  • Kawasaki Disease and Coronary Complications
  • Inflammasome and Immune Disorders
  • Systemic Lupus Erythematosus Research
  • Coronary Artery Anomalies
  • Rheumatoid Arthritis Research and Therapies
  • Adolescent and Pediatric Healthcare

Frequent co-authors in Cimaz's research collaborations are Teresa Giani, Marco Cattalini, Gabriele Simonini, Roberto Caporali, and Francesco La Torre. These collaborations reflect interdisciplinary approaches across rheumatology and pediatric medicine.

Key publication venues where Cimaz has contributed include:

  • Annals of the Rheumatic Diseases
  • Pediatric Rheumatology
  • Frontiers in Pediatrics
  • Pediatric Drugs
  • The Journal of Pediatrics

Notable recent papers involve investigations into COVID-19's impact on rheumatic diseases and pediatric inflammatory conditions, reflecting timely and ongoing research interests:

  • "COVID-19 infection and rheumatoid arthritis: Faraway, so close!" (2020) - Autoimmunity Reviews
  • "JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis" (2020) - Clinical Rheumatology
  • "Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey" (2021) - Pediatric Rheumatology
  • "Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic" (2020) - The Journal of Pediatrics
  • "What is the true incidence of COVID-19 in patients with rheumatic diseases?" (2020) - Annals of the Rheumatic Diseases

Rolando Cimaz has also contributed to academic books published by Frontiers Media, with titles addressing Kawasaki disease and pediatric rheumatology, published in 2021 and 2023 respectively.

Their scholarly work positions them within a network of research focused on immunological mechanisms, clinical presentation, and therapeutic strategies relating to autoimmune and inflammatory diseases affecting both children and adults.

Best Publications

  • Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

    Jurgen Sota;Antonella Insalaco;Rolando Cimaz;Maria Alessio

  • Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis

    Nicolino Ruperto;Hermine I. Brunner;Pierre Quartier;Tamás Constantin

  • A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

    Pierre Quartier;Florence Allantaz;Rolando Cimaz;Pascal Pillet

  • Anti-inflammatory and immunosuppressive drugs and reproduction.

    Monika Østensen;Munther Khamashta;Michael Lockshin;Ann Parke

  • Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling

    Gillian I Rice;Yoandris del Toro Duany;Yoandris del Toro Duany;Emma M Jenkinson;Gabriella M A Forte

  • Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women

    Antonio Brucato;Micol Frassi;Franco Franceschini;Rolando Cimaz

  • Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.

    Kiran Nistala;Stuart Adams;Helen Cambrook;Simona Ursu

  • COVID-19 infection and rheumatoid arthritis: Faraway, so close!

    Ennio Giulio Favalli;Francesca Ingegnoli;Orazio De Lucia;Gilberto Cincinelli

  • Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

    Chiea Chuen Khor;Chiea Chuen Khor;Sonia Davila;Sonia Davila;Willemijn B. Breunis;Yi Ching Lee

  • Localized scleroderma in childhood is not just a skin disease.

    Francesco Zulian;Cristina Vallongo;Patricia Woo;Ricardo Russo

  • Treating juvenile idiopathic arthritis to target: recommendations of an international task force

    Angelo Ravelli;Alessandro Consolaro;Gerd Horneff;Ronald M Laxer

  • The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry

    H. J. Lachmann;R. Papa;K. Gerhold;L. Obici

  • Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies.

    Rolando Cimaz;Dawn L. Spence;Lisa Hornberger;Earl D. Silverman

  • Pediatric Antiphospholipid Syndrome: Clinical and Immunologic Features of 121 Patients in an International Registry

    Tadej Avčin;Rolando Cimaz;Earl D. Silverman;Ricard Cervera

  • EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

    Nicolino Ruperto;Seza Ozen;Angela Pistorio;Pavla Dolezalova

  • Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.

    Lorenzo Cosmi;Rolando Cimaz;Laura Maggi;Veronica Santarlasci

  • Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD

    Isabelle Koné-Paut;Fahrad Shahram;Martha Darce-Bello;Luca Cantarini

  • Prevention of flare recurrences in childhood‐refractory chronic uveitis: An open‐label comparative study of adalimumab versus infliximab

    Gabriele Simonini;Andrea Taddio;Marco Cattalini;Roberto Caputo

  • Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.

    Maria Luisa Bianchi;Rolando Cimaz;Maria Bardare;Francesco Zulian

  • Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

    C Lomater;V Gerloni;M Gattinara;J Mazzotti

Frequent Co-Authors

Angelo Ravelli
Angelo Ravelli University of Genoa
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Nicolino Ruperto
Nicolino Ruperto Istituto Giannina Gaslini
Seza Ozen
Seza Ozen Hacettepe University
Alberto Martini
Alberto Martini University of Genoa
Francesco Annunziato
Francesco Annunziato University of Florence
Angela Tincani
Angela Tincani University of Brescia
Laura Maggi
Laura Maggi Sapienza University of Rome
Lorenzo Cosmi
Lorenzo Cosmi University of Florence
Marco Gattorno
Marco Gattorno Istituto Giannina Gaslini

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA doesn’t always mean becoming a doctor. There are many rewarding healthcare careers accessible through flexible online study. For those interested in pharmacy, online pharm d programs allow you to prepare for licensure and advanced roles while balancing other commitments.

The field of healthcare technology is also booming. Earning a health information management degree online can lead to roles managing patient data and supporting the digital transformation of healthcare systems.

If you’re looking for an in-demand, entry-level opportunity, medical billing and coding online courses can quickly prepare you for essential roles in clinics, hospitals, or private practices.

Advanced nursing is another pathway with strong job prospects. The cheapest np programs online offer an affordable and accessible route for registered nurses to become nurse practitioners (NPs), filling critical healthcare gaps across the country.

Best Scientists Citing Rolando Cimaz

Trending Scientists

Recently Published Articles